
Organ Transplant Logistics in Device Design
In this Before the Build episode, Eric Olson and Paul Charlebois dive into the importance of organ transplant logistics when designing effective medical devices. Paul shares a firsthand story of a deeply immersive contextual inquiry—one that involved midnight flights, last-minute changes, and an unpredictable transplant timeline.
Paul had been supporting the design of a system to manage the complex journey of donor organs from one hospital to another. But to truly understand that process, he had to live it. That meant packing a bag in advance, waiting by the phone for weeks, and finally jumping into action with just hours of notice. The result? A whirlwind 36-hour experience across multiple provinces, involving private charters, winter ambulance rides, trauma ward delays, and rapid surgical coordination between transplant teams.
The Human Side of Contextual Inquiry
This episode highlights how organ transplant logistics are shaped not just by clinical steps, but by real-world timing, transportation, and interpersonal communication. Paul describes the emotional and operational challenges—from waiting on skeleton crews to dealing with unpredictable road conditions—all of which impact how devices are used in the field.
These moments revealed details that never would have emerged in a traditional design session. Usability insights came from the chaos of real-time decisions, the pace of communication, and even a nurse’s reaction to an ambulance driver’s speed.
Why Field Immersion Matters
As Paul says, you can’t replicate this level of understanding in a workshop or survey. Only by embedding within the entire transplant process could his team return with requirements grounded in reality—and ultimately design a better, more relevant solution.
Enjoying Before the Build? Sign up to get new episodes sent to your inbox.
Related Resources

Every phase of a device’s life cycle involves different people with distinct needs—from clinicians and patients to service technicians and regulatory bodies.

Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices.

Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed.

You’ve cleared the toughest engineering hurdles and proven your design works. Then, just as you prepare to scale, your contract manufacturer turns you down.